Teva/Mylan Deal Doesn’t Stir Pharma ETFs

On a down day for U.S. stocks, even the latest rumor of a mega pharmaceuticals deal is proving ineffective in propping up exchange traded funds tracking the industry. Multiple media outlets are reporting that Israeli generic drug giant Teva Pharmaceuticals (NasdaqGS: TEVA) is mulling a bid for...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.